The Human Genome Project Aims for 2003
Laurie Goodman The plan itself includes such words as ''ambitious'' and even ''audacious,'' reflecting the committee's own perception that the agenda is one that will require extreme diligence and effort to achieve. The most notable point is the call for the completion of the human genome sequence in the year 2003-a full 2 years earlier than originally planned and corresponding to the 50th anniversary of the discovery of the double helix structure of DNA (Watson and Crick 1953) .
The proposal was approved by the NHGRI council and by the U.S. Department of Energy (DOE); human genome project research in the U.S. is sponsored jointly by the NHGRI at the National Institutes of Health (NIH) and the Office of Biological Environmental Research at the DOE. Approximately two-thirds of the human genome sequence is estimated to be completed by NIH-and DOE-funded projects and the remainder by international Wellcome Trust-funded projects.
In addition to the new time frame for the completion of the human genome sequence, the plan also covers new agendas for the (often overlooked) wide range of other areas embraced under the heading of the Human Genome Project. New plans are in effect for supporting and developing novel technology (from sequencing hardware to computer software); setting goals for model organisms; devising genomic resources, such as cDNA libraries, for the broader biological community; educating and establishing new resources in manpower; and continuing programs to investigate the impact of this new genetic information on the ethical, legal, and social aspects of the population. To a great extent, whether or not the 2003 mark for the complete sequence is the publicly funded project's response to private sector plans is rather unimportant when taken out of context with respect to what the scientific community will be getting. If the publicly funded projects were sacrificing quality and completeness for speed in a response to private sector plans, this would indeed be unacceptable. One of the clear aims of the publicly funded projects has been their target of a highly accurate (error rate = 1 ⁄10,000), long-range contiguous sequence for the human genome. That this remains the final goal of the public project even with the earlier 2003 date is the most important factor for the scientific community.
or Bust
There are two points in this 5-year agenda that are expressly new to the overall human genome sequencing plan. One point is that roughly onethird of the sequence, that is, approximately 1 Gb of sequence with several contigs of no less than 20 Mb in length, will be finished by 2001. This is achievable because of advances in technology over the last 5 years and expected advances in the upcoming years as well as the anticipated scale-up of the best methodologies for sequencing as determined over the last 5 years. A peerreview process will also be set in place to prioritize specific regions to be finished first. Such ranking of genome regions will reflect the needs of the international scientific community and should dovetail with the sequencing strategies at the time, such that large-scale sequencing disruptions are at a minimum. The addition of a selection process for sequencing specific areas of interest or gene-rich regions may reflect a desire to provide early public availability of regions that may otherwise end up solely in the hands of the private sector; con-
Box 1. Human Genome Project Goals for 1998-2003
• cerns about what effect having large amounts of DNA information tied up in intellectual property rights will have on the public welfare are still unresolved. The second new addition to the plan is the generation of what is being called a ''working draft'' of the human genome by 2001. This draft will be based on mapped clones that provide at least 90% coverage of the genome, will have a 99% accuracy, and should be quite useful for finding genes. The one issue stressed about this working draft is that it is a stage that must be passed through in the progress toward the final sequenced genome goal. This was an essential component of the plan, as no one wanted to shunt money into generating a quick, low-quality version of the genome sequence that would ultimately be discarded once the completed version could take its place. The concern here is twofold: (1) the perceived waste of money in generating something that would ultimately be discarded and (2) the potential that the lower-quality version could possibly be chosen as an ersatz final version were it deemed appropriate by individuals with narrower goals for the use of the sequence.
The Gold-Standard Version of the sequence proposed for 2003 does retain a few caveats, which the board was careful in trying to define. Several committee members expressed concern that 2003 would arrive and, without a more detailed indication of what a ''finished'' sequence was, there was always the potential to simply claim the human genome sequence complete. As indicated by a footnote in the proposal, the board expects that there will remain some regions (an indeterminate, though likely rare, number) that will prove difficult to clone and sequence. The other regions not likely to be finished by 2003 include highly repeated sequences in the centromeres and constitutive heterochromatic regions. Thus, the complete sequence for the human genome in 2003 is expected to retain some gaps that require closure. The completed sequence therefore refers to that portion of human DNA that can be stably cloned and sequenced by current technology.
Not Just Sequence
Publicly funded projects embrace a great deal beyond just determining the human genome sequence. Thus any comparison of money spent and completion of goals by privately and publicly funded projects must take into account the additional aspects provided by each.
That the 5-year plan for the human genome project covers more than just human genome sequencing per se is made immediately apparent by the fact that Goal 1 covers the completion of the human genome sequence, whereas Goals 2-8 cover all the additional components that are also under the umbrella of the publicly funded Human Genome Project (see Box 1). These areas have long-term impact not only on the simple achievement of the completion of the human genome sequence by the desired date, but on our ability to understand and use this information.
New technology, better methodologies, and more advanced bioinformatics analysis tools and resources are required for progress in sequencing capability. This is not only essential to meet the 2003 completion date, but also to establish efficient and inexpensive means to continue to utilize high-throughput sequencing technology for additional experimental purposes beyond this date. Genomic studies in model organisms, comparative studies, and further bioinformatics advances are absolutely required to aid in deciphering genome sequences (from gene identification to gene function) and in dissecting whole chomosome function, evolution, and activity. The biological community in general has made tremendous use of EST resources and will benefit more so from planned cDNA libaries, cell line, and DNA sample libraries. Obviously, an entire highly trained work force is required to carry out these plans, and training, funding, and encouraging establishment of such skilled individuals is therefore included in the goals defined for the next 5 years. Finally, all this work and planning could be worth very little if the public ultimately rejects the potential benefits from the genome projects because of misconceptions or fear of the potential misuse or abuse of this newfound knowledge. Thus, the importance of the ethical, legal, and social Implications (ELSI) programs can not be overstated. Scientists and the general public must come together in making decisions about how this information is to be used in both clinical and nonclinical settings.
Taking the entire new 5-year plan in at a glance, ''bold'' may be too tame a word.
